https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-24 / Front Oncol 2017;7:179
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-24 / Front Oncol 2017;7:1792017-08-24 00:00:002017-08-24 00:00:00Oncolytic Viral Therapy for Mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-22 / Blood 2017 10;130(15):1713-1721
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-22 / Blood 2017 10;130(15):1713-17212017-08-22 00:00:002019-02-15 08:32:49Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e52017-08-14 00:00:002017-08-14 00:00:00Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2017-08-10 11:41:232019-02-10 11:41:48IOZK ist Partner im Primo Medico Netzwerk
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-01 / Melanoma Res 2017 08;27(4):351-357
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-01 / Melanoma Res 2017 08;27(4):351-3572017-08-01 00:00:002017-08-01 00:00:00Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
